What is the mainstay of treatment of chronic bacterial prostatitis (CBP)?

Updated: May 25, 2021
  • Author: Samantha D Kraemer, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

Fluoroquinolones are the mainstay in the treatment of CBP. Fosfomycin has been shown to have good activity against extended-spectrum beta-lactamase producing organisms. Azithromycin may be more effective for Chlamydia infections. Most other antimicrobial agents are unlikely to eradicate the infection.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!